CVE-2025-61940 - CVE House
Back to Database
Status published High CVE-2025-61940

Mirion Medical EC2 Software NMIS BioDose Use of Client-Side Authentication

Vulnerability Description

NMIS/BioDose V22.02 and previous versions rely on a common SQL Server user account to access data in the database. User access in the client application is restricted by a password authentication check in the client software but the underlying database connection always has access. The latest version of NMIS/BioDose introduces an option to use Windows user authentication with the database, which would restrict this database connection.

Impact Analysis

Refer to official advisory for detailed impact metrics.

Remediation

Ensure systems are updated to the latest vendor-supplied patch levels.

THREAT MONITOR

Am I Vulnerable?

Launch our assessment wizard to check if your infrastructure is exposed to • CVE-2025-61940

Credits & Attribution

The following person or organization is credited with identifying this vulnerability, as recorded in the NVD database:

  • Joe Dillon reported these vulnerabilities to Mirion Medical.

References

More from Mirion Medical

View All →
CVE-2025-64778
Mirion Medical EC2 Software NMIS BioDose Use of Hard-coded Credentials
High 8.4
CVE-2025-64642
Mirion Medical EC2 Software NMIS BioDose Incorrect Permission Assignment for Critical Resource
High 7.1
CVE-2025-64298
Mirion Medical EC2 Software NMIS BioDose Incorrect Permission Assignment for Critical Resource
High 8.6
CVE-2025-62575
Mirion Medical EC2 Software NMIS BioDose Incorrect Permission Assignment for Critical Resource
High 8.7

Affected Vendor

Mirion Medical

View all reports →

Affected Software

EC2 Software NMIS BioDose
Vulnerable Versions:
0, 23.0

Timeline

Official Publish: December 2nd, 2025
Last Modified: December 9th, 2025
Added to House: July 22nd, 2026

CVSS Vectors

V3: CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:L

Weaknesses (CWE)

CWE-603

MITRE ATT&CK TTPs

No associated TTPs found for this vulnerability.